Clinical Centre of Serbia   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Belgrade Serbia (1983)

Organization Overview

First Clinical Trial
2009
NCT01211925
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Clinical Center of Serbia in Belgrade, Clinic for Vascular and Endovascular Surgery | Clinical Centre of Sebria | Clinical Centre of Serbia

Active Ingredients

Drugs in Phase 4 Trials (1)

saccharomyces boulardii (1 trial)

Drugs in Phase 3 Trials (2)

acetylsalicylic acid (aspirin) (2 trials)

ticagrelor (brilinta) (1 trial)

Drugs in Other Trials (1)

heparin (liquaemin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Helicobacter Infections (Phase 4)

Infarction (Phase 3)

Infections (Phase 4)

Ischemia (Phase 3)

Myocardial Infarction (Phase 3)

ST Elevation Myocardial Infarction (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4